Faculty Opinions recommendation of Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy.

Author(s):  
Jay Koyner
2008 ◽  
Vol 74 (7) ◽  
pp. 901-909 ◽  
Author(s):  
Christina L. Klein ◽  
Tom S. Hoke ◽  
Wen-Feng Fang ◽  
Christopher J. Altmann ◽  
Ivor S. Douglas ◽  
...  

2007 ◽  
Vol 293 (1) ◽  
pp. F30-F40 ◽  
Author(s):  
Heitham T. Hassoun ◽  
Dmitry N. Grigoryev ◽  
Mihaela L. Lie ◽  
Manchang Liu ◽  
Chris Cheadle ◽  
...  

Acute kidney injury (AKI) is associated with significant mortality, which increases further when combined with acute lung injury. Experiments in rodents have shown that kidney ischemia-reperfusion injury (IRI) facilitates lung injury and inflammation. To identify potential ischemia-specific lung molecular pathways involved, we conducted global gene expression profiling of lung 6 or 36 h following 1) bilateral kidney IRI, 2) bilateral nephrectomy (BNx), and 3) sham laparotomy in C57BL/6J mice. Bronchoalveolar lavage fluid analysis revealed increased total protein, and lung histology revealed increased cellular inflammation following IRI, but not BNx, compared with sham controls. Total RNA from whole lung was isolated and hybridized to 430MOEA (22,626 genes) GeneChips ( n = 3/group), which were analyzed by robust multichip average and significance analysis of microarrays and linked to gene ontology (GO) terms using MAPPFinder. The microarray power analysis predicted that the false discovery rate ( q < 1%) and ≥50%-fold change compared with sham would represent significant changes in gene expression. Analysis identified 266 and 455 ischemia-specific, AKI-associated lung genes with increased expression and 615 and 204 with decreased expression at 6 and 36 h, respectively, compared with sham controls. Real-time PCR analysis validated select array changes in lung serum amyloid A3 and endothelin-1. GO analysis revealed significant activation ( Z > 1.95) of several proinflammatory and proapoptotic biological processes. Ischemic AKI induces functional and transcriptional changes in the lung distinct from those induced by uremia alone. Further investigation using this lung molecular signature induced by kidney IRI will provide mechanistic insights and new therapies for critically ill patients with AKI.


2011 ◽  
Vol 80 (5) ◽  
pp. 504-515 ◽  
Author(s):  
Jianlin Chen ◽  
John R. Hartono ◽  
Reji John ◽  
Michael Bennett ◽  
Xin Jin Zhou ◽  
...  

2012 ◽  
Vol 303 (6) ◽  
pp. F864-F872 ◽  
Author(s):  
Nilesh Ahuja ◽  
Ana Andres-Hernando ◽  
Christopher Altmann ◽  
Rhea Bhargava ◽  
Jasna Bacalja ◽  
...  

Serum IL-6 is increased in patients with acute kidney injury (AKI) and is associated with prolonged mechanical ventilation and increased mortality. Inhibition of IL-6 in mice with AKI reduces lung injury associated with a reduction in the chemokine CXCL1 and lung neutrophils. Whether circulating IL-6 or locally produced lung IL-6 mediates lung injury after AKI is unknown. We hypothesized that circulating IL-6 mediates lung injury after AKI by increasing lung endothelial CXCL1 production and subsequent neutrophil infiltration. To test the role of circulating IL-6 in AKI-mediated lung injury, recombinant murine IL-6 was administered to IL-6-deficient mice. To test the role of CXCL1 in AKI-mediated lung injury, CXCL1 was inhibited by use of CXCR2-deficient mice and anti-CXCL1 antibodies in mice with ischemic AKI or bilateral nephrectomy. Injection of recombinant IL-6 to IL-6-deficient mice with AKI increased lung CXCL1 and lung neutrophils. Lung endothelial CXCL1 was increased after AKI. CXCR2-deficient and CXCL1 antibody-treated mice with ischemic AKI or bilateral nephrectomy had reduced lung neutrophil content. In summary, we demonstrate for the first time that circulating IL-6 is a mediator of lung inflammation and injury after AKI. Since serum IL-6 is increased in patients with either AKI or acute lung injury and predicts prolonged mechanical ventilation and increased mortality in both conditions, our data suggest that serum IL-6 is not simply a biomarker of poor outcomes but a pathogenic mediator of lung injury.


Sign in / Sign up

Export Citation Format

Share Document